Opioid-Free Anesthesia in Modified Radical Mastectomy
Efficacy of Opioid-Free Anesthesia in Modified Radical Mastectomy
1 other identifier
observational
116
1 country
1
Brief Summary
The aim of this study is to evaluate the efficacy of opioid-free general anesthesia for breast surgeries in female patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedFirst Submitted
Initial submission to the registry
December 16, 2022
CompletedFirst Posted
Study publicly available on registry
January 23, 2023
CompletedJanuary 23, 2023
January 1, 2023
2.7 years
December 16, 2022
January 11, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Post operative Morphone use
Patients who received Morphine at different time points in function of the two study groups
up to 24 hours
Time To Extubation (TTE)
Time to Extubation in function of the two study groups
Directly intraOp
Secondary Outcomes (1)
Post Operative Nausea and Vomiting (PONV)
Up to 24hours
Study Arms (2)
Group 1 consisting of treated patients using OFA
Group 1 consisted of 56 (Mean age was 54±14 years)
Group 2 consisting of treated patients using NOFA
Group 2 consisted of 60 patients (Mean age was 51±12 years)
Interventions
opioid-free general anesthesia vs non opioid-free general anesthesia
Eligibility Criteria
Between January 2018 and September 2020, data from admitted patients for modified radical mastectomy under general anesthesia were enrolled.
You may qualify if:
- Patients underwenting modified radical mastectomy
- Undergoing general anesthesia
You may not qualify if:
- Patients were excluded if they had Alzheimer's Disease, mental retardation, failure of locoregional anesthesia, contraindication for locoregional anesthesia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Etienne El Heloulead
Study Sites (1)
Lebanese Hospital Geitaoui-University Medical Center
Beirut, Lebanon
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
December 16, 2022
First Posted
January 23, 2023
Study Start
January 1, 2018
Primary Completion
September 30, 2020
Study Completion
December 1, 2020
Last Updated
January 23, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share